help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Schepper, J.
Right arrow Articles by Bourguignon, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Schepper, J.
Right arrow Articles by Bourguignon, J. P.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 489-494, Copyright © 1994 by Endocrine Society

ARTICLES

Growth hormone therapy in Turner's syndrome: one versus two daily injections

J De Schepper, M Craen, G Massa, C Heinrichs, M Maes, M Du Caju, L Rausin and JP Bourguignon
Department of Pediatrics, University of Brussels, Belgium.

In 44 girls with Turner's syndrome, aged 4.0-15.3 yr, the effects of biosynthetic GH (25 U/m2.week) given as once daily or twice daily injections were compared. During 1 yr of treatment, the growth rate increased similarly by 3.5 +/- 1.3 cm/yr in the once daily group and 2.7 +/- 1.8 cm/yr in the twice daily group. Although pretreatment height velocity was negatively related to age, the increase in height velocity during therapy was not. The mean progression in bone age (TW2- RUS method), during therapy was 1.3 yr in both groups. No significant change in the median insulin secretory response to an oral glucose tolerance test was found. Serum cholesterol and triglyceride concentrations did not change significantly throughout the study in either treatment group. Thyroid hormone concentrations remained within normal limits. Normal increments in left ventricular wall thickness and left ventricular mass for age and body surface were observed after 1 yr of GH treatment. We conclude that division of the daily GH dose given to Turner's syndrome patients into two injections does not result in either a significantly different growth response or different side- effects from once daily treatment during the first year of therapy.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
G. Massa, C. Heinrichs, S. Verlinde, M. Thomas, J. P. Bourguignon, M. Craen, I. Francois, M. Du Caju, M. Maes, and J. De Schepper
Late or Delayed Induced or Spontaneous Puberty in Girls with Turner Syndrome Treated with Growth Hormone Does Not Affect Final Height
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4168 - 4174.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T. C J Sas, S M P F d. M. Keizer-Schrama, T. Stijnen, A van Teunenbroek, A C S Hokken-Koelega, J J J Waelkens, G G Massa, T. Vulsma, W J Gerver, H M Reeser, et al.
Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections
Arch. Dis. Child., January 1, 1999; 80(1): 36 - 41.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-C. Carel, L. Mathivon, C. Gendrel, J.-P. Ducret, and J.-L. Chaussain
Near Normalization of Final Height with Adapted Doses of Growth Hormone in Turner's Syndrome
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1462 - 1466.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society